# Evaluation of the Efficacy of QUITOXIL® in Smoking Cessation

> **NCT07722832** · NA · NOT_YET_RECRUITING · sponsor: **KLAVA Innovation** · enrollment: 606 (estimated)

## Conditions studied

- Tobacco Use Disorder

## Interventions

- **DEVICE:** Quitoxil®
- **DRUG:** Nicotine Replacement Therapies

## Key facts

- **NCT ID:** NCT07722832
- **Lead sponsor:** KLAVA Innovation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2028-04-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 606 (ESTIMATED)
- **Last updated:** 2026-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07722832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07722832, "Evaluation of the Efficacy of QUITOXIL® in Smoking Cessation". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07722832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*